Abstract
Purpose
The acute respiratory distress syndrome (ARDS) represents a major challenge for clinicians as well as basic scientists. The mortality rate for ARDS has been maintained within the range of 40–52%. The authors have examined the involvement of the “cardiotonic steroids” in the pathogenesis and therapy of ARDS. We have studied the possible role of the bufadienolide, marinobufagenin (MBG), in the pathogenesis of ARDS in both a rat model of ARDS and in patients afflicted with that disorder. In addition, the potential therapeutic benefit of an antagonist of MBG, resibufogenin (RBG), in an animal model has been evaluated.
Method
A syndrome resembling human ARDS was produced in the rat by exposing the animals to 100% oxygen for 48 h. In other animals, RBG was administered to these “hyperoxic” rats, and the serum MBG was measured. In human ICU patients, urinary samples were examined for levels of MBG, and the values were compared to those obtained from other ICU patients admitted with diagnoses other than ARDS.
Results
(1) Exposure of rats to hyperoxia produced a histologic picture which resembled that of human ARDS. (2) Serum levels of MBG in the “hyperoxic” rats substantially exceeded those obtained in animals exposed to ambient oxygen levels and were reduced to normal by RBG. (3) In ARDS patients, substantial elevations in urinary MBG were obtained compared to those in non-ARDS ICU patients.
Conclusions
MBG may serve as an important biomarker for the development of ARDS, and RBG may represent a preventative/therapy in this disorder.
Similar content being viewed by others
Notes
A life threatening disorder characterized by severe hypoxemia, dyspnea, and bilateral pulmonary opacities in radiographic and computed tomographic (CT) scans.
An endogenous bufadienolide that regulates the ubiquitous Na+/K+ ATPase enzyme and is implicated in states characterized by volume expansion and increased vascular permeability.
A pregnancy-specific disorder characterized by high blood pressure and proteinuria.
A bufadienolide that is an antagonist of MBG and it is shown to prevent all of the manifestations of preeclampsia in a rat model.
Abbreviations
- ARDS:
-
Acute Respiratory Distress Syndrome
- MBG:
-
Marinobufagenin
- RBG:
-
Resibufogenin
- PE:
-
Preeclampsia
References
Rubenfeld GD, Caldwell E, Peabody E et al (2005) Incidence and outcomes of acute lung injury. N Engl J Med 353(16):1685–1693. doi:10.1056/NEJMoa050333
Matthay MA, Zimmerman GA (2005) Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 33(4):319–327. doi:10.1165/rcmb.F305
Matthay MA, Ware LB, Zimmerman GA (2012) The acute respiratory distress syndrome. J Clin Invest 122(8):2731–2740. doi:10.1172/JCI60331
Blondonnet R, Constantin JM, Sapin V et al (2016) A pathophysiologic approach to biomarkers in acute respiratory distress syndrome. Dis Markers 2016:3501373. doi:10.1155/2016/3501373
Doyle RL, Szaflarski N, Modin GW et al (1995) Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med. doi:10.1164/ajrccm.152.6.8520742
Sloane PJ, Gee MH, Gottlieb JE et al (1992) A multicenter registry of patients with acute respiratory distress syndrome: physiology and outcome. Am Rev Respir Dis 146(2):419–426. doi:10.1164/ajrccm/146.2.419
Heffner JE, Zamora CA (1990) Clinical predictors of prolonged translaryngeal intubation in patients with the adult respiratory distress syndrome. Chest 97(2):447–452
Fowler AA, Hamman RF, Good JT et al (1983) Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med 98(5 Pt 1):593–597
Hudson LD, Milberg JA, Anardi D et al. (1995) Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med. doi:10.1164/ajrccm.151.2.7842182
Pepe PE, Potkin RT, Reus DH et al (1982) Clinical predictors of the adult respiratory distress syndrome. Am J Surg 144(1):124–130
Calfee CS, Eisner MD, Ware LB et al (2007) Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit Care Med 35(10):2243–2250
Pelosi P, Brazzi L, Gattinoni L (2002) Prone position in acute respiratory distress syndrome. Eur Respir J 20(4):1017–1028
Meade MO, Cook DJ, Guyatt GH et al (2008) Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299(6):637–645. doi:10.1001/jama.299.6.637
Ortiz-Diaz E, Festic E, Gajic O et al (2013) Emerging pharmacological therapies for prevention and early treatment of acute lung injury. Semin Respir Crit Care Med 34(4):448–458. doi:10.1055/s-0033-1351118
Bagrov AY, Fedorova OV (1998) Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries. J Hypertens 16(12 Pt 2):1953–1958
Fedorova OV, Kolodkin NI, Agalakova NI et al (2001) Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats. Hypertension 37(2 Pt 2):462–466
Pamnani MB, Chen S, Yuan CM et al. (1994) Chronic blood pressure effects of bufalin, a sodium-potassium ATPase inhibitor, in rats. Hypertension 23 (1 Suppl):I106–109**
Schoner W (2002) Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem 269(10):2440–2448
Uddin MN, Horvat D, Childs EW et al (2009) Marinobufagenin causes endothelial cell monolayer hyperpermeability by altering apoptotic signaling. Am J Physiol Regul Integr Comp Physiol 296(6):R1726–R1734. doi:10.1152/ajpregu.90963.2008
Ing NH, Berghman L, Abi-Ghanem D et al (2014) Marinobufagenin regulates permeability and gene expression of brain endothelial cells. Am J Physiol Regul Integr Comp Physiol 306(12):R918–R924. doi:10.1152/ajpregu.00499.2013
Vu HV, Ianosi-Irimie MR, Pridjian CA et al (2005) Involvement of marinobufagenin in a rat model of human preeclampsia. Am J Nephrol 25(5):520–528. doi:10.1159/000088461
Pugin J, Verghese G, Widmer MC et al (1999) The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 27(2):304–312
Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342(18):1334–1349. doi:10.1056/NEJM200005043421806
Matthay MA, Zimmerman GA, Esmon C et al (2003) Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 167(7):1027–1035. doi:10.1164/rccm.200208-966WS
Horvat D, Severson J, Uddin MN et al (2010) Resibufogenin prevents the manifestations of preeclampsia in an animal model of the syndrome. Hypertens Pregnancy 29(1):1–9. doi:10.3109/10641950802629709
Puschett JB (2012) Marinobufagenin predicts and resibufogenin prevents preeclampsia: a review of the evidence. Am J Perinatol 29(10):777–785. doi:10.1055/s-0032-1316447
Folkesson HG, Matthay MA (2006) Alveolar epithelial ion and fluid transport: recent progress. Am J Respir Cell Mol Biol 35(1):10–19. doi:10.1165/rcmb.2006-0080SF
Johnson MD, Bao HF, Helms MN et al (2006) Functional ion channels in pulmonary alveolar type I cells support a role for type I cells in lung ion transport. Proc Natl Acad Sci U S A 103(13):4964–4969. doi:10.1073/pnas.0600855103
Fang X, Fukuda N, Barbry P et al (2002) Novel role for CFTR in fluid absorption from the distal airspaces of the lung. J Gen Physiol 119(2):199–207
Force ADT, Ranieri VM, Rubenfeld GD et al (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307(23):2526–2533. doi:10.1001/jama.2012.5669
Abi-Ghanem D, Lai X, Berghman LR et al (2011) A chemifluorescent immunoassay for the determination of marinobufagenin in body fluids. J Immunoass Immunochem 32(1):31–46. doi:10.1080/15321819.2010.538107
Moorthy B, Parker KM, Smith CV et al (2000) Potentiation of oxygen-induced lung injury in rats by the mechanism-based cytochrome P-450 inhibitor, 1-aminobenzotriazole. J Pharmacol Exp Ther 292(2):553–560
The Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342(18):1301–1308. doi:10.1056/NEJM200005043421801
Pelosi P, Tubiolo D, Mascheroni D et al (1998) Effects of the prone position on respiratory mechanics and gas exchange during acute lung injury. Am J Respir Crit Care Med 157(2):387–393. doi:10.1164/ajrccm.157.2.97-04023
Mure M, Martling CR, Lindahl SG (1997) Dramatic effect on oxygenation in patients with severe acute lung insufficiency treated in the prone position. Crit Care Med 25(9):1539–1544
Blanch L, Mancebo J, Perez M et al (1997) Short-term effects of prone position in critically ill patients with acute respiratory distress syndrome. Intensive Care Med 23(10):1033–1039
Mercat A, Richard JC, Vielle B et al (2008) Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299(6):646–655. doi:10.1001/jama.299.6.646
Briel M, Meade M, Mercat A et al (2010) Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 303(9):865–873. doi:10.1001/jama.2010.218
Ferguson ND, Cook DJ, Guyatt GH et al (2013) High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med 368(9):795–805. doi:10.1056/NEJMoa1215554
Young D, Lamb SE, Shah S et al (2013) High-frequency oscillation for acute respiratory distress syndrome. N Engl J Med 368(9):806–813. doi:10.1056/NEJMoa1215716
Zapol WM, Snider MT, Hill JD et al (1979) Extracorporeal membrane oxygenation in severe acute respiratory failure: a randomized prospective study. JAMA 242(20):2193–2196
Manktelow C, Bigatello LM, Hess D et al (1997) Physiologic determinants of the response to inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 87(2):297–307
Meade MO, Cook DJ, Griffith LE et al (2008) A study of the physiologic responses to a lung recruitment maneuver in acute lung injury and acute respiratory distress syndrome. Respir Care 53(11):1441–1449
Filippatos GS, Hughes WF, Qiao R et al (1997) Mechanisms of liquid flux across pulmonary alveolar epithelial cell monolayers. In Vitro Cell Dev Biol Anim 33(3):195–200. doi:10.1007/s11626-997-0141-z
Goodman BE, Fleischer RS, Crandall ED (1983) Evidence for active Na+ transport by cultured monolayers of pulmonary alveolar epithelial cells. Am J Physiol 245(1):C78–C83
Mason RJ, Williams MC, Widdicombe JH et al (1982) Transepithelial transport by pulmonary alveolar type II cells in primary culture. Proc Natl Acad Sci U S A 79(19):6033–6037
Matalon S, Benos DJ, Jackson RM (1996) Biophysical and molecular properties of amiloride-inhibitable Na+ channels in alveolar epithelial cells. Am J Physiol 271(1 Pt 1):L1–L22
Matthay MA, Folkesson HG, Verkman AS (1996) Salt and water transport across alveolar and distal airway epithelia in the adult lung. Am J Physiol 270(4 Pt 1):L487–L503
Borok Z, Liebler JM, Lubman RL et al (2002) Na transport proteins are expressed by rat alveolar epithelial type I cells. Am J Physiol Lung Cell Mol Physiol 282(4):L599–L608. doi:10.1152/ajplung.00130.2000
Johnson MD, Widdicombe JH, Allen L et al (2002) Alveolar epithelial type I cells contain transport proteins and transport sodium, supporting an active role for type I cells in regulation of lung liquid homeostasis. Proc Natl Acad Sci U S A 99(4):1966–1971. doi:10.1073/pnas.042689399
Ridge KM, Rutschman DH, Factor P et al (1997) Differential expression of Na-K-ATPase isoforms in rat alveolar epithelial cells. Am J Physiol 273(1 Pt 1):L246–L255
Danchuk S, Sukhanov S, Horvat D et al (2008) Effects of resibufogenin in experimental hypertension. Am J Nephrol 28(1):8–13. doi:10.1159/000108756
Fedorova OV, Simbirtsev AS, Kolodkin NI et al (2008) Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension. J Hypertens 26(12):2414–2425. doi:10.1097/HJH.0b013e328312c86a
Fridman AI, Matveev SA, Agalakova NI et al (2002) Marinobufagenin, an endogenous ligand of alpha-1 sodium pump, is a marker of congestive heart failure severity. J Hypertens 20(6):1189–1194
Bagrov AY, Fedorova OV, Dmitrieva RI et al (1998) Characterization of a urinary bufodienolide Na+, K+-ATPase inhibitor in patients after acute myocardial infarction. Hypertension 31(5):1097–1103
Davis EF, Lazdam M, Lewandowski AJ et al (2012) Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics 129(6):e1552–e1561. doi:10.1542/peds.2011-3093
Tian J, Haller S, Periyasamy S et al (2010) Renal ischemia regulates marinobufagenin release in humans. Hypertension 56(5):914–919. doi:10.1161/HYPERTENSIONAHA.110.155564
Uddin MN, McLean LB, Hunter FA et al (2009) Vascular leak in a rat model of preeclampsia. Am J Nephrol 30(1):26–33. doi:10.1159/000193220
Brown MA, Zammit VC, Lowe SA (1989) Capillary permeability and extracellular fluid volumes in pregnancy-induced hypertension. Clin Sci 77(6):599–604
LaMarca HL, Morris CA, Pettit GR et al (2006) Marinobufagenin impairs first trimester cytotrophoblast differentiation. Placenta 27(9–10):984–988. doi:10.1016/j.placenta.2005.12.004
Bagrov AY, Fedorova OV, Austin-Lane JL et al (1995) Endogenous marinobufagenin-like immunoreactive factor and Na+, K + ATPase inhibition during voluntary hypoventilation. Hypertension 26(5):781–788
Schoner W, Scheiner-Bobis G (2007) Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol 293(2):C509–C536. doi:10.1152/ajpcell.00098.2007
Vadasz I, Raviv S, Sznajder JI (2007) Alveolar epithelium and Na, K-ATPase in acute lung injury. Intensive Care Med 33(7):1243–1251. doi:10.1007/s00134-007-0661-8
Mutlu GM, Sznajder JI (2005) Mechanisms of pulmonary edema clearance. Am J Physiol Lung Cell Mol Physiol 289(5):L685–L695. doi:10.1152/ajplung.00247.2005
Lecuona E, Trejo HE, Sznajder JI (2007) Regulation of Na, K-ATPase during acute lung injury. J Bioenerg Biomembr 39(5–6):391–395. doi:10.1007/s10863-007-9102-1
Bachofen M, Weibel ER (1982) Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 3(1):35–56
Bachofen M, Weibel ER (1977) Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am Rev Respir Dis 116(4):589–615. doi:10.1164/arrd.1977.116.4.589
Donnelly SC, Haslett C, Reid PT et al (1997) Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 3(3):320–323
Dedhia HV, Ma JY, Vallyathan V et al (1993) Exposure of rats to hyperoxia: alteration of lavagate parameters and macrophage function. J Toxicol Environ Health 40(1):1–13. doi:10.1080/15287399309531772
Nakos G, Kitsiouli EI, Tsangaris I et al (1998) Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components. Intensive Care Med 24(4):296–303
Uddin MN, Horvat D, Glaser SS, Mitchell BM, Puschett JB (2008) Examination of the cellular mechanisms by which marinobufagenin inhibits cytotrophoblasts function. J Biol Chem 283:17946–17953
Acknowledgements
These studies were supported by the Texas A&M University College of Veterinary Medicine and Biosciences, College Station, Texas and the Jules B. Puschett Research Endowment Fund, Houston, Texas. All the authors take responsibility for the accuracy of the data presented in this manuscript: All of them have read the manuscript prior to submission for publication. Mr. Abbas and Dr. Puschett wrote the majority of the paper which was approved by the other co-authors.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
Dr. Puschett has an equity interest in Bufogen, LLC and no other conflicts of interest. We did get permission from the Texas A&M Animal Use committee, the Baylor IRB as well as the Human Use Committee at the Baylor College of Medicine, the Texas Children’s Hospital, Houston, TX and the University of Texas-Houston/ Memorial Hermann Hospital-Human Use Committee.
Ethical Approval
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed written consent was obtained from all patients involved in this study.
Additional information
Notation of prior abstract presentation: The observations in this manuscript have been presented in abstract form at a conference, Experimental Biology 2016 held in San Diego on the 4th of April, 2016.
Rights and permissions
About this article
Cite this article
Abbas, M.M.K., Patel, B., Chen, Q. et al. Involvement of the Bufadienolides in the Detection and Therapy of the Acute Respiratory Distress Syndrome. Lung 195, 323–332 (2017). https://doi.org/10.1007/s00408-017-9989-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-017-9989-1